(January 19, 2021 – Bethesda, MD) Today, the Bladder Cancer Advocacy Network (BCAN) announced that Elizabeth Plimack, MD, MS of Fox Chase Cancer Center has agreed to serve as the new Chairperson of its Scientific Advisory Board. BCAN’s Scientific Advisory Board (SAB) is composed of distinguished leading academic urologists, oncologists, radiation oncologists, and pathologists working within the bladder cancer field, representing many of the major cancer centers in the U.S and Canada. All have made outstanding contributions in their own fields.
Andrea Maddox-Smith, CEO of BCAN, said “We are pleased that Dr. Plimack has agreed to serve as the new chairperson of our SAB. We welcome her leadership and strategic guidance on medical and clinical issues and also to ensure that BCANs programs and products are up-to-date, accurate and impartial.”
Dr. Plimack said, “It has been an honor to serve BCAN over the last decade, and I am excited to take on this new role as chair of the Scientific Advisory Board. We are fortunate in the field of bladder cancer to have created a culture of engagement and collaboration—for which BCAN as an organization deserves credit,” said Plimack. “I look forward to working with my fellow experts toward the shared goals of better understanding this disease and improving outcomes for our patients through science.”
BCAN is grateful to Dr. Gary Steinberg, immediate past Chair of the SAB, for his 11 years of service in that role. Dr. Steinberg will continue to serve as a member of the SAB. Maddox-Smith said, “We thank Dr. Steinberg for his service and dedication to the SAB and are delighted that he will continue his work.”
The Bladder Cancer Advocacy Network’s (BCAN’s) mission is to increase public awareness about bladder cancer, advance bladder cancer research and, provide educational and support services for the bladder cancer community.
Director of Communications and Marketing